MYC and Miyoshi myopathy: In MM, PKM2 was shown to be induced by the c-MYC oncogene through NIMA-related kinase 2 (NEK2), and PKM2 silencing leads to a decrease in MM cell proliferation and a cell cycle arrest at G1/S transition [69,70].